| Homologous and heterologous Covid-19 booster vaccinations RL Atmar, KE Lyke, ME Deming, LA Jackson, AR Branche, HM El Sahly, ... New England Journal of Medicine 386 (11), 1046-1057, 2022 | 567 | 2022 |
| Persistence of HIV-1 receptor–positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition J Zhu, F Hladik, A Woodward, A Klock, T Peng, C Johnston, M Remington, ... Nature medicine 15 (8), 886-892, 2009 | 452 | 2009 |
| Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection E Tronstein, C Johnston, ML Huang, S Selke, A Magaret, T Warren, ... Jama 305 (14), 1441-1449, 2011 | 356 | 2011 |
| Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection J Zhu, T Peng, C Johnston, K Phasouk, AS Kask, A Klock, L Jin, K Diem, ... Nature 497 (7450), 494-497, 2013 | 342 | 2013 |
| Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo DJ Lenschow, NV Giannakopoulos, LJ Gunn, C Johnston, AK O'Guin, ... Journal of virology 79 (22), 13974-13983, 2005 | 319 | 2005 |
| Transcriptional activation of Salmonella typhimurium invasion genes by a member of the phosphorylated response‐regulator superfamily C Johnston, DA Pegues, CJ Hueck, CA Lee, SI Miller Molecular microbiology 22 (4), 715-727, 1996 | 250 | 1996 |
| Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding C Johnston, L Corey Clinical microbiology reviews 29 (1), 149-161, 2016 | 219 | 2016 |
| Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients DF Florescu, SA Pergam, MN Neely, F Qiu, C Johnston, SS Way, J Sande, ... Biology of Blood and Marrow Transplantation 18 (5), 731-738, 2012 | 195 | 2012 |
| Status of vaccine research and development of vaccines for herpes simplex virus C Johnston, SL Gottlieb, A Wald Vaccine 34 (26), 2948-2952, 2016 | 180 | 2016 |
| Salmonella typhimurium secreted invasion determinants are homologous to Shigella lpa proteins CJ Hueck, MJ Hantman, V Bajaj, C Johnston, CA Lee, SI Miller Molecular microbiology 18 (3), 479-490, 1995 | 178 | 1995 |
| HSV-2: in pursuit of a vaccine C Johnston, DM Koelle, A Wald The Journal of clinical investigation 121 (12), 4600-4609, 2011 | 173 | 2011 |
| Helicase–primase inhibitor pritelivir for HSV-2 infection A Wald, L Corey, B Timmler, A Magaret, T Warren, S Tyring, C Johnston, ... New England Journal of Medicine 370 (3), 201-210, 2014 | 167 | 2014 |
| Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant KE Lyke, RL Atmar, CD Islas, CM Posavad, D Szydlo, RP Chourdhury, ... Cell Reports Medicine 3 (7), 2022 | 156 | 2022 |
| Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible … L Labrada, XH Liang, W Zheng, C Johnston, B Levine Journal of virology 76 (22), 11688-11703, 2002 | 156 | 2002 |
| The global roadmap for advancing development of vaccines against sexually transmitted infections: update and next steps SL Gottlieb, CD Deal, B Giersing, H Rees, G Bolan, C Johnston, P Timms, ... Vaccine 34 (26), 2939-2947, 2016 | 148 | 2016 |
| Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials C Johnston, M Saracino, S Kuntz, A Magaret, S Selke, M Huang, ... The Lancet 379 (9816), 641-647, 2012 | 145 | 2012 |
| Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects SE Frey, A Wald, S Edupuganti, LA Jackson, JT Stapleton, H El Sahly, ... Vaccine 33 (39), 5225-5234, 2015 | 142 | 2015 |
| Herpes simplex virus type 1 shedding in tears and nasal and oral mucosa of healthy adults M Ramchandani, M Kong, E Tronstein, S Selke, A Mikhaylova, A Magaret, ... Sexually transmitted diseases 43 (12), 756-760, 2016 | 141 | 2016 |
| Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection: a randomized trial RV Barnabas, ER Brown, A Bershteyn, HC Stankiewicz Karita, ... Annals of internal medicine 174 (3), 344-352, 2021 | 127 | 2021 |
| Identification of genes involved in the host response to neurovirulent alphavirus infection C Johnston, W Jiang, T Chu, B Levine Journal of virology 75 (21), 10431-10445, 2001 | 114 | 2001 |
